The human hepatoma cell line HepG2 in culture medium synthesized fatty
acids de novo (144 +/- 9 nmol fatty acid/mg protein per 24 h) at a ra
te similar to that observed in freshly prepared rat hepatocytes (192 /- 8 nmol/mg per 24 h) and in primary cultures of rat hepatocytes (165
.4 +/- 29.3 nmol/mg per 24 h). In HepG2 cells, fatty acid synthesis wa
s inhibited by extracellular oleate (0.75 mM), and, to a lesser extent
, by glucagon (10(-7) M). Insulin (7.8 x 10(-8) M) had a mild stimulat
ory effect. Fatty acid synthesis was not influenced by lipogenic precu
rsors (lactate plus pyruvate), substances which, in rat hepatocytes, h
ad pronounced stimulatory effects. Fatty acid synthesis rates were als
o unchanged in the presence of prostaglandin E(2) (PGE(2)). Tn general
, compared to rat hepatocytes, fatty acid synthesis in HepG2 cells was
less sensitive to manipulation of the culture medium in vitro. HepG2
cells had a high capacity for triacylglycerol synthesis from extracell
ular oleate (469 +/- 43 nmol triacylglycerol/mg protein per 24 h) but
phospholipid synthesis was relatively low (15.8 +/- 0.4% of total glyc
erolipids). Very little of the above newly synthesized triacylglycerol
was secreted as lipoprotein (4.62 +/- 0.88 nmol triacylglycerol/mg pr
otein per 24 h) resulting in a large intracellular accumulation of tri
acylglycerol. This was exacerbated by the absence of any detectable ke
togenesis. The secretion of triacylglycerol produced from de novo synt
hesized fatty acids was also very low in HepG2 compared to that observ
ed in primary cultures of rat hepatocytes. In HepG2, the capacity for
triacylglycerol + phospholipid synthesis from exogenous fatty acids wa
s far higher than that from endogenous synthesized fatty acids. Lipopr
otein triacylglycerol secretion was inhibited by insulin in HepG2. How
ever, glucagon and PGE(2), which inhibit this process in rat hepatocyt
es, were without effect. In contrast to rat hepatocytes, most of the l
ipoprotein triacylglycerol in HepG2 was secreted without prior lipolys
is and re-esterification of intracellular triacylglycerol. This reflec
ted a very low overall rate of intracellular triacylglycerol lipolysis
in HepG2. These results suggest that, although lipid synthesis is ver
y active in HepG2, there is a defect in lipid mobilization (lipolysis,
secretion, and oxidation) that results in excessive intracellular sto
rage of triacylglycerol.